Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-19-040872
Filing Date
2019-02-14
Accepted
2019-02-14 16:17:32
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G d632189dsc13g.htm SC 13G 36329
  Complete submission text file 0001193125-19-040872.txt   37620
Mailing Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451 617-600-7373
Minerva Neurosciences, Inc. (Subject) CIK: 0001598646 (see all company filings)

EIN.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88240 | Film No.: 19606576
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MINERVA NEUROSCIENCES, INC. 1601 TRAPELO ROAD, SUITE 286 WALTHAM MA 02451
Business Address
Luthringer Remy (Filed by) CIK: 0001610384 (see all company filings)

Type: SC 13G